CHC defends CM compliance
September 2, 2011
THE Complementary Healthcare
Council of Australia has hit back at
claims made by the Australian
National Audit Office (ANAO) that
90% of complementary products
were not compliant with current
regulations (PD yesterday).
The report looked at a TGA review
of 31 randomly selected
complementary drugs on sale in
Australia, 90% of which were not
compliant with regulatory
requirements.
According to the CHC however,
this statistic should be treated with
“severe caution” because of its
small sample size.
Furthermore the CHC argued that
the 90% statistic encompassed a
myriad of issues, including missing
full stops and wrong font sizes in
labelling.
The CHC also said that 97% of the
instances of non-compliance
identified were almost immediately
corrected to be totally compliant.
On the flip side the CHC
acknowledged that there “is room
for improvement in the regulatory
framework of the Complementary
Medicines Industry”.
The CHC also agreed with the
ANAO that there is a need to
improve the enforcement of
sanctions and penalties by the TGA.
“We strongly believe that all
medicines, including Complementary
Medicines, on the Australian
market should be of high quality,
safe, effective and readily
available,” a CHC statement said.
“We will continue our proactive
work with the TGA to ensure that
this is continues to be the case,”
the CHC added.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Sep 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Sep 11
